METTL3 also promotes the malignant proliferation of CRC cells by stabilizing m6A-modified oncogenic mRNAs (such as MYC proto-oncogene protein, MYC) or by accelerating the decay of suppressor mRNAs (such as SOCS2) (20, 52, 53). The gene discussed is METTL3; the disease is colorectal carcinoma.